US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Roundhill GLP-1 & Weight Loss ETF

31.13

-0.3199-1.02%

Post-market: 31.150.0165+0.05%19:30 EDT

Volume:9K

Turnover:272.90K

Market Cap:58.22M

PE:- -

High:31.44

Open:31.38

Low:31.13

Close:31.45

52wk High:37.15

52wk Low:25.66

Shares:1.87M

Float Shares:1.87M

Volume Ratio:0.28

T/O Rate:0.47%

Dividend:0.41

Dividend Rate:1.31%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

AlzeCure Pharma to Present at Aktiedagen Event in Stockholm

Novo Nordisk (0QIU) Receives a Hold from Barclays

Novo Nordisk halts two trials testing ziltivekimab, Bloomberg reports

Yen advances to six-month high, chip stocks rise

Nicholas Reynolds / Bloomberg

Novo Nordisk announces STEP Young phase 3 trial met its primary endpoint

Novo Nordisk (NVO) Hit by Another Heart Drug Setback

Novo Nordisk A/S Series B Stock Flat Monday, Underperforms Market

Novo Nordisk Stock (NVO) Falls Despite Success in Children’s Weight-Loss Trial

The Second Act of Biotech

ASB Ventures-Backed Boundary Zhikong’s Navista eVTOL Navigation System Enters CAAC Airworthiness Review

Novartis Cholesterol Setback Tests Hopes for Emerging Heart Disease Drugs

Novartis India to Acquire 'Minipress' Trademarks from Pfizer

Clever Culture Systems Wins Expanded Novo Nordisk Order as APAS Nears Global Validation

Pfizer Ramps Up Obesity And Eczema Bets, Investors Watch

Pfizer Inc. Stock Underperforms Friday When Compared to Competitors

Healthcare Stocks Pick up Steam as Investors Play Offense and Defense

Pfizer’s Next Move in Obesity Drugs: What the New VESPER-JM Trial Means for PFE Investors

Pfizer Steps Up in Obesity Race With New Phase 3 Berobenatide Trial in Japan

Novo Nordisk Advances New Obesity Drug NNC0721-8060 Into First Human Trial

Lilly Targets Type 1 Diabetes With New Tirzepatide Study: What Investors Should Watch

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/stock/OZEM/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"OZEM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OZEM\",,,,,undefined,":{"symbol":"OZEM","market":"US","secType":"STK","nameCN":"Roundhill GLP-1 & Weight Loss ETF","latestPrice":31.1335,"timestamp":1789156800000,"preClose":31.4534,"halted":0,"volume":8738,"hourTrading":{"tag":"盘后","latestPrice":31.15,"preClose":31.1335,"latestTime":"19:30 EDT","volume":21,"amount":653.9345,"timestamp":1789169406014,"change":0.0165,"changeRate":0.00053,"amplitude":0},"delay":0,"changeRate":-0.010170601588381446,"floatShares":1870002,"shares":1870002,"eps":0,"marketStatus":"Market Closed","change":-0.3199,"latestTime":"09-11 16:00:00 EDT","open":31.38,"high":31.438,"low":31.1335,"amount":272896.08479,"amplitude":0.009681,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":31.4534,"sharesOutstanding":1670000,"nav":31.66,"aum":59204200,"dividendRate":0.013147,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":31.15,"preClose":31.1335,"latestTime":"19:30 EDT","volume":21,"amount":653.9345,"timestamp":1789169406014,"change":0.0165,"changeRate":0.00053,"amplitude":0},"volumeRatio":0.2826313383988561,"impliedVol":0.3159,"impliedVolPercentile":0.9562},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OZEM\",,,,,undefined,":{"symbol":"OZEM","floatShares":1870002,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.2826313383988561,"shares":1870002,"dividePrice":0.4093,"high":31.438,"amplitude":0.009681,"preClose":31.4534,"low":31.1335,"week52Low":25.66,"pbRate":"--","week52High":37.15,"institutionHeld":0,"latestPrice":31.1335,"eps":0,"divideRate":0.013147,"volume":8738,"delay":0,"ttmEps":0,"open":31.38,"prevYearClose":34.1569,"prevWeekClose":33.3664,"prevMonthClose":32.8745,"prevQuarterClose":32.54,"fiveDayClose":33.5876,"twentyDayClose":33.4747,"sixtyDayClose":30.4834},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/OZEM\",params:#limit:5,,,undefined,":[{"date":"2025-12-30","symbol":"OZEM","amount":0.409914,"announcedDate":"2025-12-29","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-30","defaultRemindTime":1767105000000,"name":"Roundhill GLP-1 & Weight Loss ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-30","currency":"USD","dateTimestamp":1767070800000,"payDate":"2025-12-31"},{"date":"2024-12-30","symbol":"OZEM","amount":0.05307,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-30","defaultRemindTime":1735569000000,"name":"Roundhill GLP-1 & Weight Loss ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-31","payableDate":"2024-12-30","currency":"USD","dateTimestamp":1735534800000,"payDate":"2024-12-31"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"OZEM\",market:\"US\",,,undefined,":[{"executeDate":"2024-12-30","recordDate":"2024-12-30","paymentDate":"2024-12-31","value":0.05307,"currency":"USD"},{"executeDate":"2025-12-30","recordDate":"2025-12-30","paymentDate":"2025-12-31","value":0.409914,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"OZEM\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"OZEM\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2665323952","title":"AlzeCure Pharma to Present at Aktiedagen Event in Stockholm","url":"https://stock-news.laohu8.com/highlight/detail?id=2665323952","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665323952?lang=en_us&edition=fundamental","pubTime":"2026-09-08 16:03","pubTimestamp":1788854584,"startTime":"0","endTime":"0","summary":"AlzeCure Pharma to present at Aktiedagen event in StockholmAlzeCure will present at Aktiespararna’s Aktiedagen in Stockholm on Sept. 15.CEO Martin Jnsson is scheduled to speak at 16:25 CEST at Birger ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL83QQ0r:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKDWB100.SGD","SGXZ99366536.SGD","ELIL","LU2237443465.HKD","LU1069344957.HKD","LU1988902786.USD","LU2471134952.CNY","LU2491050071.SGD","IE00BJJMRY28.SGD","IE00BKPKM429.USD","LU0061475181.USD","LU0964807845.USD","LU1974910355.USD","LU2491050154.USD","LU2491049909.HKD","FTXH","LU2746668974.SGD","LU2471134796.USD","BK4534","LU1093756168.USD","LU0471298694.HKD","LU2236285917.USD","LU0109391861.USD","SGXZ51526630.SGD","LU2168564222.USD","IE00B4JS1V06.HKD","LU0354030438.USD","LU1127390331.HKD","LU2357305700.SGD","SG9999015945.SGD","LU1057294990.SGD","LU0820561818.USD","IE00B2B36J28.USD","LU0133085943.USD","LU2089284900.SGD","LU2756315664.SGD","IE00BFSS7M15.SGD","LU2237443382.USD","LU0058720904.USD","LU2089984988.USD","LU0787776722.HKD","LU0006306889.USD","IE0002141913.USD","LU0345770993.USD","LU0106261372.USD","LU0882574055.USD","LU2023250504.SGD","LU0708995401.HKD","LU2471134879.HKD","LU2168564065.EUR","TMED","BK4516","LU2106854487.HKD","IHE","IE0001KFT4U8.USD","IE0005OL40V9.USD","LU0096364046.USD","LU1814569148.SGD","LU1917777945.USD","IE00BJJMRX11.SGD","LU2265009873.SGD","IE0004445239.USD","IE00BN29S564.USD","IE00B775H168.HKD","LU1983299246.USD","LU0158827948.USD","LU0417517546.SGD","IE00BWXC8680.SGD","MEDI","LU2461242641.AUD","LU2462157665.USD","LU2756315318.SGD","LU2063271972.USD","LU1868837136.USD","GB00BDT5M118.USD","HRTS","LU1629891620.HKD","LU0882574139.USD","CURE","AGNG","LU1267930730.SGD","JDOC","LU2168564495.EUR","SG9999018857.SGD","LU0079474960.USD","LU2896262040.SGD","LU2361044865.SGD","LU2237443895.HKD","LU0320765059.SGD","LU2456880835.USD","LU0354030511.USD","LU0266013472.USD","BK4588","IE00B1BXHZ80.USD","LU0097036916.USD","LU2552382058.USD","LU0353189680.USD","TRUH","LU0786609619.USD","SG9999001176.USD","LU1868836591.USD","LU0471298777.SGD","SG9999014914.USD","IE0009355771.USD","LU0174119429.USD","LLYZ","LU2264538146.SGD","LU0345770308.USD","IE00BJJMRZ35.SGD","LU0316494557.USD","LU2361044949.HKD","IE00B4R5TH58.HKD","LU0683600562.USD","LU2211815571.USD","WDNA","RXL","LU0466842654.USD","PJP","LU0823434740.USD","LU0210536198.USD","LU1720051017.SGD","LU2213496289.HKD","LLY","SG9999014880.SGD","LU1548497426.USD","LU0456855351.SGD","LU0203201768.USD","LU1989771016.USD","IE00B1XK9C88.USD","LU2471134523.USD","SG9999015978.USD","BK4581","LU1720051108.HKD","MHIP","LU1232071149.USD","LU1291159041.SGD","LU1551013342.USD","IE00BJT1NW94.SGD","LU0203202063.USD","LU0094547139.USD","LU2108987350.USD","SGXZ81514606.USD","LU0640476718.USD","LU1979441026.SGD","LU0432979614.USD","LU0820561909.HKD","BK4585","LU0323591593.USD","LU2028103732.USD","VHT","LU0198837287.USD","LU2087625088.SGD","SG9999015952.SGD","LU1093756325.SGD","SG9999018865.SGD","LU2111349929.HKD","IE00B7KXQ091.USD","IE00BJLML261.HKD","LLYX","LU0109394709.USD","LU0158827781.USD","LU2089283258.USD","FHLC","LU1061106388.HKD","LU0353189763.USD","MEDX","OZEM","SGXZ57979304.SGD","ILDR","LU2237443549.SGD","LU1064131342.USD","LU0823416689.USD","LU1868836757.USD","LU2462591350.SGD","IE00BK4W5L77.USD","IXJ","LU2023250330.USD","SG9999001176.SGD","LU2271345857.HKD","LU0238689110.USD","LU1868836914.USD","LU2112291526.USD","IE00BFSS8Q28.SGD","LU1023059063.AUD","CANC","LU2237443978.SGD","LU0689472784.USD","LU2750360997.AUD","LU1323610961.USD","IE0004445015.USD","LU1623119135.USD","LU1868837300.USD","LU0823434583.USD","LU0943347566.SGD","SG9999013999.USD","LU2361045086.USD","LU2417539215.USD","LU0114720955.EUR","BK4007","LU0122379950.USD","LU0320765992.SGD","LU0672654240.SGD","BK4533","LU2168563687.JPY","LU2468319806.SGD","PPH","LU2552382132.HKD","LU1145028129.USD","LU2168564149.EUR","LU2237438978.USD","SGXZ31699556.SGD","LU1280957306.USD","LU2746668461.USD","LU0234572021.USD","IYH","LLII","IE00BFTCPJ56.SGD","LU0256863811.USD","LU2552382215.SGD","LU2750360641.GBP","SG9999014906.USD","LU2324357040.USD","LU0225283273.USD","SG9999014898.SGD","LU0889565916.HKD","GDOC","LU1366192091.USD","LU1804176565.USD","LU1035775433.USD","THNR","LU0289739699.SGD","LU1551013425.SGD","ELIS","LU2360106947.USD","BK4599","LU1691799644.USD","LU0256863902.USD","LU0385154629.USD","LU1712237335.SGD","SG9999015986.USD","LU2602419157.SGD","LU0820562030.AUD","SG9999017495.SGD","LU2023251221.USD","IE00BK4W5M84.HKD","XLV","LU2237443622.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665328428","title":"Novo Nordisk (0QIU) Receives a Hold from Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2665328428","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665328428?lang=en_us&edition=fundamental","pubTime":"2026-09-08 15:25","pubTimestamp":1788852330,"startTime":"0","endTime":"0","summary":"Barclays analyst James Gordon CFA maintained a Hold rating on Novo Nordisk today and set a price target of DKK300.00. According to TipRanks, Gordon...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/novo-nordisk-0qiu-receives-a-hold-from-barclays-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/novo-nordisk-0qiu-receives-a-hold-from-barclays-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVO","IE00BZ1G4Q59.USD","NVOH","PPH","BK4532","LU0154236417.USD","NVOC","THNR","BK4007","OZEM","IE00BKVL7J92.USD","BK4585","NVOX","BK4599","BK4588","LU1093756168.USD","LU1093756325.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665631001","title":"Novo Nordisk halts two trials testing ziltivekimab, Bloomberg reports","url":"https://stock-news.laohu8.com/highlight/detail?id=2665631001","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665631001?lang=en_us&edition=fundamental","pubTime":"2026-09-08 05:40","pubTimestamp":1788817216,"startTime":"0","endTime":"0","summary":"Novo Nordisk (NVO) has halted two trials testing if ziltivekimab, its experimental heart disease medicine, would help patients with heart failure, ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novo-nordisk-halts-two-trials-testing-ziltivekimab-bloomberg-reports-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novo-nordisk-halts-two-trials-testing-ziltivekimab-bloomberg-reports-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4599","BK4532","BK4007","NVO","LU1093756168.USD","OZEM","THNR","BK4588","NVOC","NVOH","PPH","LU0154236417.USD","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","NVOX","LU1093756325.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665376683","title":"Yen advances to six-month high, chip stocks rise","url":"https://stock-news.laohu8.com/highlight/detail?id=2665376683","media":"Nicholas Reynolds / Bloomberg","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665376683?lang=en_us&edition=fundamental","pubTime":"2026-09-08 02:14","pubTimestamp":1788804840,"startTime":"0","endTime":"0","summary":"The yen extended Monday's advance to reach the strongest level since February, aided by rising expectations of a Bank of Japan interest-rate increase next week.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"edge_highlight","url":"https://www.theedgesingapore.com/news/highlight/stocks-asia-poised-edge-down-yen-focus?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theedgesingapore.com/news/highlight/stocks-asia-poised-edge-down-yen-focus?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"edge_highlight","symbols":["SGXZ31699556.SGD","IE00BQXX3F31.USD","LU2054465674.USD","LU1720051108.HKD","LU1935042488.USD","SG9999000418.SGD","LU0345774391.USD","LU0971096721.USD","LU2360032135.SGD","LU2756315664.SGD","LU0130102774.USD","LU0640476718.USD","JPM","LU1670628061.USD","LU0056508442.USD","UBRL","LU0215105999.USD","SG9999015986.USD","LU0127658192.USD","LU1093756325.SGD","LU2213496289.HKD","LU2237443549.SGD","LU1267930813.SGD","ADBU","LU1629891620.HKD","LU0976567544.SGD","LU1623119135.USD","LU0211326755.USD","IE0034235303.USD","BK4527","LU0985489474.SGD","LU1674673691.USD","LU0868494617.USD","LU1935043023.USD","LU1861219969.SGD","LU2746668974.SGD","OGIG","LU2237443622.USD","LU1989764664.SGD","LU0965509101.SGD","BK4536","LU0265550359.USD","SG9999001424.SGD","IE00B5TLWC47.USD","LU0511384066.AUD","LU1037948541.HKD","LU2746668461.USD","LU0345770993.USD","NVOH","LU1674673428.USD","LU2023250330.USD","LU1989772923.USD","LU0082616367.USD","LU0792757196.USD","UBER","LU0175139822.USD","LU0980610538.SGD","LU1670627923.USD","LU1988902786.USD","LU2237957811.SGD","IE00BJTD4V19.USD","BK4528","BK4023","LU2168563687.JPY","LU1861214812.USD","LU2125154935.USD","LU2242649171.HKD","LU0342679015.USD","LU1261432733.SGD","LU0289961442.SGD","ORCS","WNDR","SG9999018857.SGD","LU1989764748.USD","BK4550","LU0496365809.HKD","LU0965509283.SGD","IE00BDRTCR15.USD","LU1894683348.USD","LU0107464264.USD","LU0198837287.USD","LU0882574139.USD","LU0251132253.USD","IE00BDCRKT87.USD","LU0320765646.SGD","IE00B5949003.HKD","LU0353189763.USD","LU0472753341.HKD","LU1069347547.HKD","LU0106831901.USD","LU2505996509.AUD","LU1815333072.USD","LU0154236417.USD","LU1668664300.SGD","LU2095319765.USD","SG9999014880.SGD","LU2237438978.USD","LU0444973449.USD","BK4007","LU1551013425.SGD","BK4516","LU1894683264.USD","IE00BK4W5L77.USD","SG9999014906.USD","LU2211815571.USD","FNCL","LU0265550946.USD","LU0353189680.USD","LU0859254822.USD","IE00BJTD4N35.SGD","LU1316542783.SGD","LU1084165304.USD","LU1119994496.HKD","LU2505996681.GBP","NVOX","LU0310799852.SGD","LU1366192091.USD","IE00BFMHRM44.USD","KBWB","IE00BZ199S13.USD","LU1064131342.USD","BK4585","IE00BMPRXR70.SGD","LU0203345920.USD","BK4534","LU2552382058.USD","LU0048584097.USD","LU2360107325.USD","LU1506573853.SGD","BK4599","BK4022","BK4538","LU0708995401.HKD","LU0345774631.USD","LU2458330169.SGD","LU0320765059.SGD","LU0006306889.USD","LU0256863902.USD","LU2210150020.SGD","LU1116320737.USD","IYF","LU0208291251.USD","LU2360106780.USD","LU2097829019.USD","LU2417539215.USD","LU0158827948.USD","LU0187121727.USD","LU0648001328.SGD","SG9999015945.SGD","LU2023251221.USD","LU2357305700.SGD","LU0738911758.USD","LU2317271919.USD","LU2896262040.SGD","LU2430703178.SGD","LU0868494708.USD","LU0348723411.USD","IE0034235188.USD","LU0820561909.HKD","LU0068578508.USD","LU2381873111.SGD","SG9999015952.SGD","SGXZ81514606.USD","LU0314104364.USD","IE00BJLML261.HKD","LU2357627491.SGD","ADBE","LU2106854487.HKD","LU2089284900.SGD","FTXO","LU1093756168.USD","LU2458330243.SGD","LU1046421795.USD","LU0689472784.USD","LU1201861249.SGD","LU1778281490.HKD","IE000M9KFDE8.USD","IE00B775SV38.USD","LU1934455863.HKD","LU2237443978.SGD","LU0690374961.EUR","IE0009356076.USD","LU0965509010.AUD","IE00B7SZLL34.SGD","VFH","IE00BYQQ9H92.USD","LU0149725797.USD","IYG","LU0267386448.USD","BK4207","IE00BN8TJ469.HKD","LU1280957306.USD","LU1366333091.USD","LU1935043536.SGD","LU2237443895.HKD","LU0417517546.SGD","BK4592","BK4503","IE00BQXX3C00.GBP","ORCL","BK4230","LU1720051017.SGD","LU0081259029.USD","LU0642271901.SGD","SG9999002232.USD","LU1934455194.USD","IE00BKVL7J92.USD","LU2108987350.USD","LU1267930730.SGD","BK4581","TDIV","LU2244417387.USD","LU2023250843.SGD","LU0211327993.USD","LU1489326972.SGD","LU2210149790.SGD","SGXZ51526630.SGD","LU1548497426.USD","LU0106261372.USD","LU0170899867.USD","ORCX","IYT","LU0345769128.USD","LU1633808545.USD","ORCZ","IE00BLSP4452.SGD","UYG","GB00BDT5M118.USD","LU0820562030.AUD","SG9999002224.SGD","LU0211326839.USD","ADBG","ORCU","LU0719512351.SGD","LU1032466523.USD","SG9999018865.SGD","LU1162221912.USD","LU1003077747.HKD","IE00BKDWB100.SGD","LU1814569148.SGD","BK4533","LU2552382215.SGD","LU0553294199.USD","LU1803068979.SGD","LU1934455277.USD","IE00B19Z9505.USD","LU1823568750.SGD","JPO","IE00BHPRN162.USD","UBEW","LU1244550221.USD","IE0034235295.USD","LU1429558221.USD","LU0889566641.SGD","LU1037948897.HKD","SG9999014898.SGD","LU0234570918.USD","LU0661504455.SGD","LU2756315318.SGD","LU2543165471.USD","IE0002270589.USD","LU1244550577.SGD","SG9999014914.USD","IE00BK4W5M84.HKD","IE00BYXW3230.USD","SORCLmain","TRUF","LU0210536198.USD","LU1496350502.SGD","BK4566","LU0545039389.USD","LU0949170772.SGD","LU2860962120.EUR","LU1551013342.USD","LU2552382132.HKD","LU2592432038.USD","LU0203347892.USD","LU0211331839.USD","LU0878866978.SGD","SGXZ99366536.SGD","LU0289960550.SGD","JPMO","LU2087625088.SGD","FDRV","LU2264538146.SGD","GB00B4LPDJ14.GBP","BK4097","BK4567","LU2430703095.HKD","TFNS","LU2089283258.USD","LU0943347566.SGD","LU2404859741.USD","LU0070302665.USD","LU1974910355.USD","LU1267930490.SGD","IE00BMPRXQ63.HKD","LU0444971666.USD","LU2125154778.USD","BK4551","IXG","LU0433182093.SGD","LU0889565833.HKD","LU0057025933.USD","LU1435385759.SGD","LU2237443382.USD","LU2456880835.USD","LU0942090050.USD","LU0552385451.USD","LU2250418816.HKD","LU1852331112.SGD","LU0683600562.USD","LU2237957902.USD","SG9999011175.SGD","LU2326559502.SGD","IE00B1BXHZ80.USD","LU2430703251.USD","NVO","LU2168564065.EUR","LU0238689110.USD","IE0004445239.USD","THNR","LU1712237335.SGD","LU1691799644.USD","LU1116320901.HKD","LU2404859667.USD","LU0965508806.USD","LU0820561818.USD","IE00B19Z3B42.SGD","LU0289739343.SGD","LU0957808578.USD","IE00BFXG0V08.USD","LU0345770308.USD","LU1035773651.USD","LU0256863811.USD","LU1917777945.USD","BK4505","SG9999017495.SGD","LU0964807845.USD","LU1935042215.USD","LU0211328371.USD","LU1244550494.USD","LU0069063385.USD","IE00B19Z3581.USD","LU0476273544.USD","LU1914381329.SGD","LU2168564222.USD","IE00BMPRXN33.USD","LU1989772840.SGD","LU1235294995.USD","LU1642822529.SGD","IE00BLSP4239.USD","IE00BBT3K403.USD","SG9999003800.SGD","LU2237443465.HKD","LU0672654240.SGD","LU2168564149.EUR","LU2462157665.USD","GB00B4QBRK32.GBP","BK4535","XLF","BK4504","LU0157215616.USD","LU2236285917.USD","BK4588","LU0109391861.USD","LU2168564495.EUR","LU0109392836.USD","LU0861579265.USD","LU1815336760.USD","IE00B3S45H60.SGD","IE00BFXG1179.USD","LU1145028129.USD","LU1363072403.SGD","IE00BZ1G4Q59.USD","LU0557290698.USD","LU0690374615.EUR","BK4543","PPH","LU0061474960.USD","OZEM","LU0323591593.USD","IE00BQXX3D17.EUR","LU0787776722.HKD","LU1496350171.SGD","NVOC","IGV","SG9999015978.USD","LU1983260115.SGD","ORAC","LU0234572021.USD","LU2023250504.SGD","BK4532","BK4554","TPOR","LU0314106906.USD","LU0345769631.USD","LU1935042991.SGD","LU0957791311.USD","IE00B1XK9C88.USD","LU0320765489.SGD","IE00BWXC8680.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665109773","title":"Novo Nordisk announces STEP Young phase 3 trial met its primary endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2665109773","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665109773?lang=en_us&edition=fundamental","pubTime":"2026-09-08 02:10","pubTimestamp":1788804610,"startTime":"0","endTime":"0","summary":"Novo Nordisk (NVO) announced first results from the STEP Young phase 3 trial, evaluating once-weekly semaglutide in combination with a reduced-calo...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novo-nordisk-announces-step-young-phase-3-trial-met-its-primary-endpoint-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novo-nordisk-announces-step-young-phase-3-trial-met-its-primary-endpoint-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVOH","NVO","NVOX","OZEM","LU0154236417.USD","BK4599","NVOC","BK4588","LU1093756168.USD","BK4007","PPH","IE00BKVL7J92.USD","THNR","LU1093756325.SGD","IE00BZ1G4Q59.USD","BK4585","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665862310","title":"Novo Nordisk (NVO) Hit by Another Heart Drug Setback","url":"https://stock-news.laohu8.com/highlight/detail?id=2665862310","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665862310?lang=en_us&edition=fundamental","pubTime":"2026-09-08 00:56","pubTimestamp":1788800218,"startTime":"0","endTime":"0","summary":"Novo Nordisk ($NVO) has halted two late‑stage studies of its experimental heart drug ziltivekimab, marking a major setback in its push into cardiov...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/novo-nordisk-nvo-hit-by-another-heart-drug-setback?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/novo-nordisk-nvo-hit-by-another-heart-drug-setback?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVOC","THNR","NVOX","BK4532","LU0154236417.USD","NVO","IE00BZ1G4Q59.USD","BK4588","LU1093756168.USD","NVOH","IE00BKVL7J92.USD","PPH","BK4007","LU1093756325.SGD","OZEM","BK4599","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665731749","title":"Novo Nordisk A/S Series B Stock Flat Monday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2665731749","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665731749?lang=en_us&edition=fundamental","pubTime":"2026-09-08 00:02","pubTimestamp":1788796920,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novo Nordisk A/S Series B were flat  at DKK298.95 Monday on what proved to be an overall positive trading session for the stock market, with the OMX Nordic 40 Index rising 0.3% to 2,710.84.The stock's rise  snapped a two-day losing streak.The company closed DKK111.00 short of its 52-week high of DKK409.95, which the company reached on January 23, 2026.Trading volume was 1,797,150, compared to the 50-day average trading volume of 4,122,224.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVO","NVOH","LU0154236417.USD","PPH","THNR","LU1093756325.SGD","BK4532","LU1093756168.USD","NVOC","IE00BKVL7J92.USD","BK4588","BK4007","BK4599","NVOX","OZEM","BK4585","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665131175","title":"Novo Nordisk Stock (NVO) Falls Despite Success in Children’s Weight-Loss Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2665131175","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665131175?lang=en_us&edition=fundamental","pubTime":"2026-09-07 20:32","pubTimestamp":1788784376,"startTime":"0","endTime":"0","summary":"Novo Nordisk’s ($NVO) shares in Copenhagen edged lower on Monday afternoon. This came even after the Danish pharma giant said in a statement that i...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/novo-nordisk-stock-nvo-falls-despite-success-in-childrens-weight-loss-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/novo-nordisk-stock-nvo-falls-despite-success-in-childrens-weight-loss-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4585","NVOC","LU1093756168.USD","NVOH","BK4588","NVO","THNR","BK4532","BK4599","PPH","OZEM","IE00BZ1G4Q59.USD","LU1093756325.SGD","LU0154236417.USD","IE00BKVL7J92.USD","NVOX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665531933","title":"The Second Act of Biotech","url":"https://stock-news.laohu8.com/highlight/detail?id=2665531933","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665531933?lang=en_us&edition=fundamental","pubTime":"2026-09-07 19:08","pubTimestamp":1788779310,"startTime":"0","endTime":"0","summary":"Pfizer sells dopamine. Moderna made the COVID vaccine. Both are betting their next decade on medicines that barely existed when their stocks peaked...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-second-act-of-biotech?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-second-act-of-biotech?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","LU1066051498.USD","IE00BLSP4452.SGD","SG9999002232.USD","LU1894683264.USD","BK4585","BK4534","BK4568","LU0985481810.HKD","MRNA","IE000M9KFDE8.USD","BK4533","LU0225284248.USD","LU0122379950.USD","BK4550","LU0225771236.USD","LU0234572021.USD","SG9999001176.SGD","BK4592","IE00BLSP4239.USD","SG9999003800.SGD","SGXZ57979304.SGD","BK4581","SG9999001176.USD","IE0002270589.USD","IE00B3T34201.USD","SG9999011175.SGD","IE00B19Z3581.USD","LU1894683348.USD","LU0289739699.SGD","BK4532","LU2596442595.SGD","PFE","LU0868494617.USD","WDNA","MRNY","SG9999013999.USD","BK4548","OZEM","IE00B19Z3B42.SGD","LU0321505439.SGD","GNOM","LU0456855351.SGD","BK4599","LU1023059063.AUD","LU1883839398.USD","IDNA","LU0306806265.USD","LU0170899867.USD","BK4501","LGHT","LU0306807586.USD","LU1057294990.SGD","LU1066053197.SGD","BK4551","BK4588","MRNX","LU0058720904.USD","SG9999002224.SGD","BK4139","IE00BBT3K403.USD","LU0321505868.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665023390","title":"ASB Ventures-Backed Boundary Zhikong’s Navista eVTOL Navigation System Enters CAAC Airworthiness Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2665023390","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665023390?lang=en_us&edition=fundamental","pubTime":"2026-09-07 16:35","pubTimestamp":1788770131,"startTime":"0","endTime":"0","summary":"ASB Ventures-backed Boundary Zhikong’s Navista eVTOL navigation system enters CAAC airworthiness reviewShenzhen ASB Ventures portfolio company Boundary Intelligent Control secured CAAC acceptance of a","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nNDL7rkwzT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0114720955.EUR","LU2750360997.AUD","BK4599","LLII","LU1868837136.USD","LU0471298777.SGD","LU2264538146.SGD","IE00B4R5TH58.HKD","SGXZ81514606.USD","LU0882574055.USD","LU2108987350.USD","LU2552382215.SGD","IXJ","LU0106261372.USD","LU0234572021.USD","BK4534","LU2896262040.SGD","LU1623119135.USD","LU2357305700.SGD","THNR","LU2491050071.SGD","LU2468319806.SGD","LU2237438978.USD","LU2360106947.USD","LU2089283258.USD","LU2271345857.HKD","LU2237443895.HKD","LU2089984988.USD","SGXZ57979304.SGD","LU2491049909.HKD","LU1267930730.SGD","IE00B4JS1V06.HKD","SG9999015945.SGD","LU1093756325.SGD","LU2023250504.SGD","JDOC","IE00BJJMRZ35.SGD","ELIS","LU2168564065.EUR","PPH","IE00BK4W5L77.USD","IE0004445239.USD","LU1868836757.USD","LU2168564222.USD","CURE","LU1551013342.USD","LU2602419157.SGD","LU0353189763.USD","LU0210536198.USD","LU1868836591.USD","LU1127390331.HKD","IE0002141913.USD","BK4211","LU1323610961.USD","SG9999015978.USD","LU0289739699.SGD","FHLC","IE00BN29S564.USD","LU0820561818.USD","LU1548497426.USD","GB00BDT5M118.USD","LU2456880835.USD","LU1280957306.USD","LU2471134796.USD","LU2106854487.HKD","LU1868836914.USD","LU0345770993.USD","LU1979441026.SGD","IE00BFSS8Q28.SGD","LU1551013425.SGD","LU1989771016.USD","LU0323591593.USD","LU0061475181.USD","LU2361044949.HKD","SG9999018865.SGD","GDOC","LU1629891620.HKD","LU2112291526.USD","LU2471134952.CNY","LU2756315664.SGD","LU0708995401.HKD","SG9999014914.USD","LU0174119429.USD","LU0079474960.USD","LU0345770308.USD","LU0689472784.USD","LU1232071149.USD","IE00BJJMRX11.SGD","LU0417517546.SGD","LU0354030511.USD","LU1093756168.USD","LU0256863902.USD","LU2063271972.USD","LU1720051017.SGD","LU2237443382.USD","LU0238689110.USD","LU0889565916.HKD","LU2552382058.USD","LU0109394709.USD","LU2111349929.HKD","ASB","LU2461242641.AUD","LU1291159041.SGD","IE0005OL40V9.USD","LU1366192091.USD","MEDX","LU2028103732.USD","LU0320765059.SGD","LU2756315318.SGD","SG9999017495.SGD","LU0640476718.USD","MEDI","LU0096364046.USD","SG9999015986.USD","LU0058720904.USD","LU1720051108.HKD","LU2089284900.SGD","LU2023251221.USD","LLYZ","IE00BK4W5M84.HKD","IE00BKDWB100.SGD","LU0158827781.USD","LU0787776722.HKD","IE00BKPKM429.USD","LU0882574139.USD","IE00BJLML261.HKD","MHIP","IE0009355771.USD","LU0316494557.USD","LU0820562030.AUD","LU0256863811.USD","LU0266013472.USD","LU1974910355.USD","LU2237443549.SGD","LU1691799644.USD","LU0354030438.USD","IHE","LU2750360641.GBP","PJP","LU2023250330.USD","LU2471134879.HKD","LU0122379950.USD","HRTS","LU1814569148.SGD","BK4533","LU1023059063.AUD","LU2746668974.SGD","SG9999001176.SGD","BK4516","LU0203201768.USD","IE00B1BXHZ80.USD","IE0001KFT4U8.USD","VHT","LU1064131342.USD","IE00B775H168.HKD","LU1069344957.HKD","LU0823434740.USD","LU1988902786.USD","OZEM","ILDR","LU1983299246.USD","LU2462591350.SGD","LLY","LU0823416689.USD","SGXZ31699556.SGD","LU2471134523.USD","SG9999014906.USD","LU0353189680.USD","SGXZ99366536.SGD","LU0471298694.HKD","IE00BFTCPJ56.SGD","LU2211815571.USD","LU2237443978.SGD","LU2491050154.USD","LU2237443622.USD","AGNG","LU0198837287.USD","LU0225283273.USD","LU0823434583.USD","ELIL","IE00BWXC8680.SGD","LU2552382132.HKD","FTXH","LU0432979614.USD","LU1804176565.USD","LU0683600562.USD","CANC","SG9999014898.SGD","LU1917777945.USD","LU2417539215.USD","SG9999015952.SGD","WDNA","SGXZ51526630.SGD","SG9999018857.SGD","LU2168564149.EUR","LU2361045086.USD","LU0109391861.USD","SG9999014880.SGD","LU0006306889.USD","IE00B1XK9C88.USD","LU1712237335.SGD","IE00B2B36J28.USD","LU2265009873.SGD","LU0203202063.USD","LU0094547139.USD","LU1145028129.USD","LU0964807845.USD","LU0786609619.USD","LU1057294990.SGD","IE0004445015.USD","LU1868837300.USD","IE00BFSS7M15.SGD","LU2746668461.USD","IYH","SG9999013999.USD","LU0820561909.HKD","LU0466842654.USD","TRUH","XLV","LU2237443465.HKD","LU2361044865.SGD","LU0320765992.SGD","LU1035775433.USD","LU0672654240.SGD","LU2213496289.HKD","IE00B7KXQ091.USD","LU0456855351.SGD","LU2236285917.USD","SG9999001176.USD","IE00BJT1NW94.SGD","LU0097036916.USD","LU2462157665.USD","LU0133085943.USD","LU0385154629.USD","TMED","LU0158827948.USD","BK4581","IE00BJJMRY28.SGD","LLYX","RXL","LU2168564495.EUR","BK4007","BK4585","LU0943347566.SGD","LU2324357040.USD","LU2168563687.JPY","LU2087625088.SGD","LU1061106388.HKD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665390614","title":"Novartis Cholesterol Setback Tests Hopes for Emerging Heart Disease Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2665390614","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665390614?lang=en_us&edition=fundamental","pubTime":"2026-09-07 16:11","pubTimestamp":1788768672,"startTime":"0","endTime":"0","summary":"UPDATE 2-Novartis cholesterol setback tests hopes for emerging heart disease drugsLONDON, Sept 7 (Reuters)-Shares of NovartisNOVN.Sfell more than 3% on Monday after its cholesterol drug failed in a cl","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nL1N44Z05O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VHT","NAMS","LU2089284900.SGD","AMGN","MEDI","PPH","IYH","CURE","PBE","IE00BJJMRY28.SGD","LLYX","LLII","MHIP","SGXZ99366536.SGD","RXL","JDOC","SLN","HRTS","THNR","TMED","ILDR","LU0823434583.USD","ELIS","LLYZ","XLV","LU2361044865.SGD","BBH","CANC","TRUH","TBXU","ELIL","MEDX","WDNA","IBBQ","FTXH","LU0097036916.USD","LU2750360641.GBP","FHLC","PJP","LLY","LU1691799644.USD","BIB","LU1267930730.SGD","GDOC","LU1571399168.USD","IHE","OZEM","AGNG","IBB","IXJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665397422","title":"Novartis India to Acquire 'Minipress' Trademarks from Pfizer","url":"https://stock-news.laohu8.com/highlight/detail?id=2665397422","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665397422?lang=en_us&edition=fundamental","pubTime":"2026-09-07 15:43","pubTimestamp":1788767020,"startTime":"0","endTime":"0","summary":"BRIEF-Novartis India To Acquire 'Minipress' Trademarks From PfizerSept 7 (Reuters)-Novartis India LtdNOIN.BO:TO ACQUIRE 'MINIPRESS' TRADEMARKS FROM PFIZERSource text:ID:nBSE74jJ9yFurther company coverage:NOIN.BO","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nFWN44Y00E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B4R5TH58.HKD","BK4578","IE00BJJMRZ35.SGD","LU0456855351.SGD","SG9999002224.SGD","PPH","IE0002141913.USD","IE0002270589.USD","IE00BLSP4239.USD","LU0070302665.USD","LU0225771236.USD","IE00B2B36J28.USD","BK4532","LU0321505439.SGD","IE00B19Z3B42.SGD","IE00BLSP4452.SGD","BK4568","LU0985481810.HKD","LU1057294990.SGD","LU1894683264.USD","LU2596442595.SGD","IE000M9KFDE8.USD","SGXZ57979304.SGD","MEDX","SG9999013999.USD","NVS","LU0211331839.USD","LU0320765489.SGD","IE00B19Z3581.USD","LU0225284248.USD","LU1023059063.AUD","LU0289739699.SGD","BK4533","BK4599","LU0234572021.USD","BK4588","IE00B3T34201.USD","OZEM","LU0208291251.USD","IE00BBT3K403.USD","LU1066053197.SGD","LU0306807586.USD","LU0868494617.USD","LU0122379950.USD","SG9999001176.SGD","SG9999011175.SGD","SG9999003800.SGD","LU0058720904.USD","IE0009355771.USD","BK4592","LU0170899867.USD","LU0321505868.SGD","BK4550","LU0306806265.USD","LU1066051498.USD","LU1883839398.USD","BK4534","SG9999002232.USD","PFE","IE00BJT1NW94.SGD","LU1894683348.USD","SG9999001176.USD","BK4585","IE00BFTCPJ56.SGD","BK4007","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665398326","title":"Clever Culture Systems Wins Expanded Novo Nordisk Order as APAS Nears Global Validation","url":"https://stock-news.laohu8.com/highlight/detail?id=2665398326","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665398326?lang=en_us&edition=fundamental","pubTime":"2026-09-07 08:23","pubTimestamp":1788740626,"startTime":"0","endTime":"0","summary":"The latest update is out from LBT Innovations Limited ( ($AU:CC5) ). Clever Culture Systems Ltd, an Adelaide-based specialist in AI microbiology au...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/clever-culture-systems-wins-expanded-novo-nordisk-order-as-apas-nears-global-validation?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/clever-culture-systems-wins-expanded-novo-nordisk-order-as-apas-nears-global-validation?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4599","LU1093756325.SGD","BK4532","NVOC","BK4585","IE00BKVL7J92.USD","PPH","THNR","IE00BZ1G4Q59.USD","NVOH","OZEM","BK4007","BK4588","BK7007","CC5.AU","LU0154236417.USD","LU1093756168.USD","NVOX","NVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665363786","title":"Pfizer Ramps Up Obesity And Eczema Bets, Investors Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2665363786","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665363786?lang=en_us&edition=fundamental","pubTime":"2026-09-05 23:02","pubTimestamp":1788620534,"startTime":"0","endTime":"0","summary":"Pfizer ( ($PFE) ) has been popular among investors this week. Here is a recap of the key news on this stock. Pfizer Inc. is quietly reshaping its l...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/weekend-updates/pfizer-ramps-up-obesity-and-eczema-bets-investors-watch?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/weekend-updates/pfizer-ramps-up-obesity-and-eczema-bets-investors-watch?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SG9999011175.SGD","SG9999013999.USD","LU1066053197.SGD","LU0170899867.USD","LU0306807586.USD","SG9999003800.SGD","LU1883839398.USD","IE0002270589.USD","LU1066051498.USD","IE00B19Z3B42.SGD","LU0321505439.SGD","IE00BLSP4239.USD","BK4533","IE00BLSP4452.SGD","BK4581","LU0225771236.USD","SG9999001176.SGD","LU1894683264.USD","BK4568","LU0306806265.USD","LU0868494617.USD","SG9999001176.USD","LU0225284248.USD","LU1023059063.AUD","IE000M9KFDE8.USD","BK4534","OZEM","PFE","IE00B19Z3581.USD","SG9999002232.USD","LU0058720904.USD","BK4592","SG9999002224.SGD","LU0321505868.SGD","LU0234572021.USD","LU2596442595.SGD","LU0985481810.HKD","IE00B3T34201.USD","BK4550","LU0122379950.USD","LU1894683348.USD","BK4585","LU1057294990.SGD","IE00BBT3K403.USD","SGXZ57979304.SGD","BK4599","BK4588","LU0289739699.SGD","BK4007","LU0456855351.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665516603","title":"Pfizer Inc. Stock Underperforms Friday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2665516603","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665516603?lang=en_us&edition=fundamental","pubTime":"2026-09-05 04:36","pubTimestamp":1788554160,"startTime":"0","endTime":"0","summary":"DJ Pfizer Inc. Stock Underperforms Friday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Pfizer Inc.  shed 1.25% to $28.45 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index  falling 0.38% to 7,718.60 and Dow Jones Industrial Average  falling 0.51% to 53,414.25.This was the stock's second consecutive day of losses.Pfizer Inc. closed 2.60% short of its 52-week high of $29.21, which the company achieved on September 3rd.The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson  fell 1.15% to $275.23, Eli Lilly & Co.  fell 0.88% to $1,149.36, and Abbott Laboratories  fell 0.42% to $108.33.Trading volume  remained 17.2 million below its 50-day average volume of 40.7 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 4, 2026.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3581.USD","LU0234572021.USD","SG9999002224.SGD","LU1894683348.USD","SG9999011175.SGD","BK4581","LU0225771236.USD","BK4007","LU0225284248.USD","SG9999013999.USD","LU1066053197.SGD","BK4568","LU0289739699.SGD","SGXZ57979304.SGD","OZEM","LU0306806265.USD","LU1057294990.SGD","SG9999002232.USD","IE00BLSP4452.SGD","LU0170899867.USD","LU0321505868.SGD","LU0985481810.HKD","LU1883839398.USD","BK4588","LU1894683264.USD","BK4550","SG9999001176.SGD","LU2596442595.SGD","IE00B19Z3B42.SGD","LU0058720904.USD","LU0321505439.SGD","IE00B3T34201.USD","SG9999001176.USD","SG9999003800.SGD","LU0306807586.USD","IE000M9KFDE8.USD","LU0868494617.USD","LU0456855351.SGD","LU1023059063.AUD","BK4534","BK4599","BK4592","IE00BLSP4239.USD","BK4533","IE0002270589.USD","LU0122379950.USD","PFE","BK4585","LU1066051498.USD","IE00BBT3K403.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665351836","title":"Healthcare Stocks Pick up Steam as Investors Play Offense and Defense","url":"https://stock-news.laohu8.com/highlight/detail?id=2665351836","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665351836?lang=en_us&edition=fundamental","pubTime":"2026-09-05 04:22","pubTimestamp":1788553320,"startTime":"0","endTime":"0","summary":"Want a prescription for investing success?","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN29S564.USD","LU2168563687.JPY","LU2213496289.HKD","LU0097036916.USD","IE0009355771.USD","LU0320765059.SGD","LU0225283273.USD","LU2750360997.AUD","IBB","LU2112291526.USD","LLYX","LU2237443978.SGD","LU0114720955.EUR","LU1035775433.USD","LU2237443549.SGD","BK4588","LU0345770993.USD","GB00BDT5M118.USD","SG9999018865.SGD","IHF","LU0640476718.USD","LU0823434583.USD","LU2168564222.USD","LU1280957306.USD","BK4534","LU0006306889.USD","LU2111349929.HKD","LU2237443622.USD","LU2417539215.USD","LU0823416689.USD","LU0456855351.SGD","LLY","LU0316494557.USD","LU1145028129.USD","LU1720051108.HKD","LU0256863902.USD","LU2491049909.HKD","IE00B4JS1V06.HKD","LABU","LU1551013425.SGD","SG9999015952.SGD","FTXH","LU0203202063.USD","LU2028103732.USD","LU2023251221.USD","BK4585","MRNX","LU0432979614.USD","LU0109394709.USD","LU2089984988.USD","LU2361045086.USD","IE0004445015.USD","LU2462591350.SGD","IE0002141913.USD","LU0943347566.SGD","LU0122379950.USD","SG9999001176.SGD","RXL","LU1064131342.USD","LU2896262040.SGD","LU0198837287.USD","LU0964807845.USD","PJP","SGXZ99366536.SGD","IE00BJJMRX11.SGD","SG9999001176.USD","IE0005OL40V9.USD","LU1093756325.SGD","LU2211815571.USD","LU0096364046.USD","LU0094547139.USD","LU1720051017.SGD","LU1691799644.USD","LU1814569148.SGD","LU2456880835.USD","GDOC","LU0354030511.USD","IE00BFSS8Q28.SGD","LLII","BK4007","LU0234572021.USD","LU2324357040.USD","LU0689472784.USD","LU2756315664.SGD","IE00BFSS7M15.SGD","LU2168564065.EUR","LLYZ","MRNY","LU0238689110.USD","LU2361044865.SGD","LU2750360641.GBP","THNR","TMED","BK4568","LU0256863811.USD","ELIS","IDNA","SG9999014898.SGD","LU1983299246.USD","IE00BJT1NW94.SGD","LU0345770308.USD","SG9999014880.SGD","LU0174119429.USD","SG9999014914.USD","BK4501","LU2491050071.SGD","IE00B775H168.HKD","LU0158827948.USD","LU2471134879.HKD","XLV","MHIP","ELIL","BK4139","SGXZ81514606.USD","LU2237443895.HKD","FHLC","LU2089284900.SGD","LU1868836591.USD","IE00BKPKM429.USD","LU1232071149.USD","LU0203201768.USD","LU2264538146.SGD","LU1868836757.USD","LU1061106388.HKD","LU0820561909.HKD","BK4548","LU2237438978.USD","LU0882574139.USD","LU0820562030.AUD","LU0787776722.HKD","IE00B2B36J28.USD","SG9999017495.SGD","LU2237443382.USD","LU2552382058.USD","LU1551013342.USD","SG9999015978.USD","SG9999015986.USD","IE00B1XK9C88.USD","BK4581","LU0882574055.USD","LU1127390331.HKD","LU0820561818.USD","LU2023250504.SGD","LU2063271972.USD","LU0683600562.USD","LU2168564495.EUR","SG9999015945.SGD","MEDX","IE00B1BXHZ80.USD","LU0320765992.SGD","WDNA","LU1366192091.USD","LU2471134523.USD","SGXZ57979304.SGD","LU0889565916.HKD","LU2265009873.SGD","LU2023250330.USD","LU1988902786.USD","LU1069344957.HKD","LGHT","LU2746668974.SGD","LU0471298694.HKD","LU0786609619.USD","LU2756315318.SGD","LU1979441026.SGD","MEDI","AGNG","IE00B7KXQ091.USD","LU0708995401.HKD","CANC","LU2087625088.SGD","IE0004445239.USD","LU0417517546.SGD","LU0058720904.USD","MRNA","LU0210536198.USD","LU1093756168.USD","LU1623119135.USD","BK4516","IE00BJJMRZ35.SGD","LU1989771016.USD","LU2168564149.EUR","SGXZ51526630.SGD","LU2462157665.USD","LU1267930730.SGD","LU2468319806.SGD","LU1917777945.USD","LU1804176565.USD","LU2237443465.HKD","LU1868837136.USD","LU2360106947.USD","LU1323610961.USD","IE00BJJMRY28.SGD","LU0061475181.USD","LU2108987350.USD","LU0079474960.USD","LU1023059063.AUD","IHE","JDOC","LU0354030438.USD","LU1548497426.USD","LU2552382215.SGD","LU2361044949.HKD","LU1291159041.SGD","LU2271345857.HKD","LU2602419157.SGD","LU0823434740.USD","OZEM","IE00BK4W5M84.HKD","LU2236285917.USD","LU2471134796.USD","IE0001KFT4U8.USD","SG9999018857.SGD","LU0471298777.SGD","ILDR","LU2357305700.SGD","LU0353189680.USD","LU2746668461.USD","LU0466842654.USD","SG9999014906.USD","LU0106261372.USD","LU0109391861.USD","BK4599","GNOM","LU0133085943.USD","IE00BFTCPJ56.SGD","LU0289739699.SGD","IE00BWXC8680.SGD","SGXZ31699556.SGD","TRUH","LU2106854487.HKD","IE00BK4W5L77.USD","LU1629891620.HKD","LU2089283258.USD","HRTS","LU0385154629.USD","LU1868837300.USD","LU0158827781.USD","LU2471134952.CNY","LU2552382132.HKD","LU0353189763.USD","SG9999013999.USD","IE00BJLML261.HKD","LU2491050154.USD","BK4533","BK4551","IE00B4R5TH58.HKD","LU1974910355.USD","LU0323591593.USD","LU2461242641.AUD","LU1868836914.USD","PPH","IE00BKDWB100.SGD","LU1712237335.SGD","LU1057294990.SGD","LU0266013472.USD","XBI","BK4532","LU0672654240.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665274353","title":"Pfizer’s Next Move in Obesity Drugs: What the New VESPER-JM Trial Means for PFE Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2665274353","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665274353?lang=en_us&edition=fundamental","pubTime":"2026-09-05 00:32","pubTimestamp":1788539536,"startTime":"0","endTime":"0","summary":"Pfizer Inc ($PFE) announced an update on their ongoing clinical study. Pfizer Inc. (PFE) has launched VESPER-JM, a Phase 3 study in Japan that test...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pfizers-next-move-in-obesity-drugs-what-the-new-vesper-jm-trial-means-for-pfe-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pfizers-next-move-in-obesity-drugs-what-the-new-vesper-jm-trial-means-for-pfe-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0306807586.USD","IE00B3T34201.USD","SG9999002224.SGD","SG9999003800.SGD","LU0868494617.USD","SG9999001176.USD","LU0289739699.SGD","OZEM","BK4585","IE00BLSP4452.SGD","LU1023059063.AUD","PFE","SG9999011175.SGD","SG9999002232.USD","SG9999013999.USD","LU0170899867.USD","LU0225771236.USD","LU0306806265.USD","IE0002270589.USD","BK4568","SG9999001176.SGD","BK4581","LU0225284248.USD","LU1894683348.USD","LU1883839398.USD","BK4534","BK4007","IE00BBT3K403.USD","BK4533","LU1894683264.USD","LU1057294990.SGD","LU0058720904.USD","LU0234572021.USD","SGXZ57979304.SGD","IE00B19Z3B42.SGD","IE000M9KFDE8.USD","BK4550","BK4592","LU0321505868.SGD","LU0456855351.SGD","LU1066053197.SGD","IE00B19Z3581.USD","LU0122379950.USD","LU0985481810.HKD","LU2596442595.SGD","BK4588","IE00BLSP4239.USD","BK4599","LU0321505439.SGD","LU1066051498.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665353242","title":"Pfizer Steps Up in Obesity Race With New Phase 3 Berobenatide Trial in Japan","url":"https://stock-news.laohu8.com/highlight/detail?id=2665353242","media":"TIPRANKS","labels":["productRelease","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665353242?lang=en_us&edition=fundamental","pubTime":"2026-09-05 00:31","pubTimestamp":1788539500,"startTime":"0","endTime":"0","summary":"Pfizer Inc ($PFE) announced an update on their ongoing clinical study. Pfizer Inc. (PFE) has launched a Phase 3 study in Japan called VESPER-JW to ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pfizer-steps-up-in-obesity-race-with-new-phase-3-berobenatide-trial-in-japan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pfizer-steps-up-in-obesity-race-with-new-phase-3-berobenatide-trial-in-japan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OZEM","LU0058720904.USD","LU0868494617.USD","SG9999002224.SGD","LU0456855351.SGD","BK4568","IE000M9KFDE8.USD","BK4550","LU1057294990.SGD","LU1066053197.SGD","SG9999001176.USD","LU1023059063.AUD","LU1883839398.USD","SG9999013999.USD","IE00BLSP4239.USD","SG9999011175.SGD","BK4581","BK4007","LU0985481810.HKD","BK4592","LU0225771236.USD","IE00B19Z3B42.SGD","SG9999002232.USD","IE00BLSP4452.SGD","LU0306807586.USD","LU0321505868.SGD","LU0225284248.USD","LU0170899867.USD","BK4585","LU1066051498.USD","BK4588","LU1894683264.USD","SGXZ57979304.SGD","IE00B19Z3581.USD","SG9999001176.SGD","SG9999003800.SGD","LU0321505439.SGD","LU1894683348.USD","LU0289739699.SGD","BK4599","IE00BBT3K403.USD","BK4533","LU2596442595.SGD","PFE","IE00B3T34201.USD","LU0122379950.USD","IE0002270589.USD","LU0306806265.USD","LU0234572021.USD","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665835320","title":"Novo Nordisk Advances New Obesity Drug NNC0721-8060 Into First Human Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2665835320","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665835320?lang=en_us&edition=fundamental","pubTime":"2026-09-05 00:31","pubTimestamp":1788539471,"startTime":"0","endTime":"0","summary":"Novo Nordisk ($NVO) announced an update on their ongoing clinical study. The study A Study Investigating Safety, Tolerability, Pharmacokinetics and...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/novo-nordisk-advances-new-obesity-drug-nnc0721-8060-into-first-human-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/novo-nordisk-advances-new-obesity-drug-nnc0721-8060-into-first-human-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","IE00BKVL7J92.USD","NVOC","NVOH","LU1093756168.USD","OZEM","THNR","IE00BZ1G4Q59.USD","LU0154236417.USD","LU1093756325.SGD","NVO","BK4007","BK4588","BK4599","PPH","BK4532","NVOX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665135376","title":"Lilly Targets Type 1 Diabetes With New Tirzepatide Study: What Investors Should Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2665135376","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665135376?lang=en_us&edition=fundamental","pubTime":"2026-09-05 00:31","pubTimestamp":1788539464,"startTime":"0","endTime":"0","summary":"Eli Lilly And Company ($LLY) announced an update on their ongoing clinical study. Eli Lilly and Company (LLY) is launching a new Phase 1 study on t...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lilly-targets-type-1-diabetes-with-new-tirzepatide-study-what-investors-should-watch?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lilly-targets-type-1-diabetes-with-new-tirzepatide-study-what-investors-should-watch?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2361045086.USD","LU0158827781.USD","SG9999013999.USD","SG9999014914.USD","LU0889565916.HKD","LU1035775433.USD","IE00BJT1NW94.SGD","IE0005OL40V9.USD","LU0640476718.USD","IE00BKDWB100.SGD","IE00BN29S564.USD","LU2324357040.USD","BK4581","LU0320765992.SGD","LU1623119135.USD","LU1127390331.HKD","LU2746668974.SGD","FTXH","LU0114720955.EUR","IE00BFTCPJ56.SGD","LU0672654240.SGD","LU1868836914.USD","SG9999014898.SGD","LU1720051108.HKD","BK4534","OZEM","IE00B4R5TH58.HKD","GB00BDT5M118.USD","LU2357305700.SGD","IE00BJJMRY28.SGD","IYH","LU0079474960.USD","LU2237443382.USD","LU0943347566.SGD","LU2089283258.USD","LU1974910355.USD","LU0323591593.USD","TRUH","LU0225283273.USD","LU2552382132.HKD","SG9999015952.SGD","SGXZ99366536.SGD","LU0787776722.HKD","LU0823434583.USD","LU1712237335.SGD","LU2417539215.USD","TMED","LU2237443978.SGD","LU1983299246.USD","LU2756315664.SGD","IE00B1BXHZ80.USD","ELIS","IE0001KFT4U8.USD","LU0133085943.USD","SGXZ31699556.SGD","VHT","LU2237443622.USD","BK4599","IE00B7KXQ091.USD","LU2087625088.SGD","LU2471134796.USD","LU1061106388.HKD","LU0345770993.USD","LU2491050071.SGD","LU1280957306.USD","LU0096364046.USD","LU2361044865.SGD","LU2552382058.USD","LU1232071149.USD","SG9999015978.USD","LU0174119429.USD","IE00B775H168.HKD","SGXZ51526630.SGD","IE0009355771.USD","LLYX","LU1069344957.HKD","LU1804176565.USD","LU0256863811.USD","LU0354030438.USD","LU0471298777.SGD","LU1868837136.USD","PPH","LU1814569148.SGD","LU0708995401.HKD","BK4533","LU1366192091.USD","LU1868837300.USD","ELIL","LU2211815571.USD","IE00BJJMRZ35.SGD","SG9999001176.USD","LU2063271972.USD","LU2264538146.SGD","IE00BK4W5L77.USD","LU0882574139.USD","LU0882574055.USD","LU2023251221.USD","IE00BJLML261.HKD","LU0820562030.AUD","LU2108987350.USD","LU0823434740.USD","IE00BFSS7M15.SGD","LU0058720904.USD","SG9999018865.SGD","LU2168564065.EUR","LU2213496289.HKD","LU2471134879.HKD","MEDX","LU0109394709.USD","MEDI","LU0320765059.SGD","LU2089284900.SGD","LU2265009873.SGD","LU2468319806.SGD","IE00BKPKM429.USD","LU2168564222.USD","SG9999015986.USD","BK4516","LU1868836591.USD","SG9999014880.SGD","LU2461242641.AUD","LU0964807845.USD","LU1629891620.HKD","SGXZ57979304.SGD","LU0823416689.USD","IE0002141913.USD","IE0004445239.USD","BK4588","LU0094547139.USD","BK4007","LU0289739699.SGD","LU2756315318.SGD","LU2750360641.GBP","LLII","WDNA","LU2023250504.SGD","SG9999015945.SGD","LU1267930730.SGD","LU0466842654.USD","LU0353189763.USD","LU0471298694.HKD","LU0820561909.HKD","LU2111349929.HKD","LU2462591350.SGD","THNR","IE00BK4W5M84.HKD","LU2750360997.AUD","IE00B1XK9C88.USD","LU0198837287.USD","IE00BWXC8680.SGD","LU1291159041.SGD","LLYZ","SG9999001176.SGD","LU0210536198.USD","LU0316494557.USD","LU2491050154.USD","LU2106854487.HKD","LU1023059063.AUD","LU1917777945.USD","LU2271345857.HKD","LU0097036916.USD","LU0203201768.USD","LU0061475181.USD","LU2471134952.CNY","LU0353189680.USD","ILDR","PJP","LU2471134523.USD","LU2896262040.SGD","IE00BJJMRX11.SGD","LU2089984988.USD","RXL","LU0385154629.USD","LU0256863902.USD","LU0122379950.USD","BK4585","LU2168564149.EUR","LU2236285917.USD","GDOC","SG9999017495.SGD","IE00BFSS8Q28.SGD","LU2462157665.USD","LU2361044949.HKD","LU0689472784.USD","LU0266013472.USD","LU2456880835.USD","SG9999018857.SGD","LU2360106947.USD","LU0432979614.USD","LU2237443895.HKD","LU2023250330.USD","LU1720051017.SGD","LU1979441026.SGD","CURE","LU1323610961.USD","LU1868836757.USD","LU2237438978.USD","SGXZ81514606.USD","AGNG","CANC","FHLC","IXJ","LU0354030511.USD","IE00B4JS1V06.HKD","LU1064131342.USD","LU0345770308.USD","LU1989771016.USD","LU2168563687.JPY","LU0203202063.USD","LLY","LU1691799644.USD","LU0820561818.USD","LU2552382215.SGD","LU0006306889.USD","LU0786609619.USD","LU0417517546.SGD","LU1551013425.SGD","MHIP","LU0158827948.USD","IE00B2B36J28.USD","LU1093756168.USD","LU2746668461.USD","IHE","HRTS","LU2237443549.SGD","IE0004445015.USD","LU0238689110.USD","LU1548497426.USD","LU1145028129.USD","LU0683600562.USD","LU2028103732.USD","LU0234572021.USD","LU2112291526.USD","LU1988902786.USD","LU0109391861.USD","JDOC","LU2491049909.HKD","XLV","LU1057294990.SGD","LU2237443465.HKD","LU0106261372.USD","SG9999014906.USD","LU1093756325.SGD","LU2602419157.SGD","LU0456855351.SGD","LU1551013342.USD","LU2168564495.EUR"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}